Blog | Process Solutions

Recent ActivityRecent Activity

Cytiva Streamlines Biopharmaceutical Production Capacity

Pharma wastes $50 billion a year in inefficient manufacturing. Learn how Cytiva is unlocking isolated data and doing more the terabyte of data per day they produce.

Main Image

The pharmaceutical industry wastes about $50 billion per year in inefficient manufacturing. That’s why companies like Cytiva (formerly GE Healthcare Life Sciences) are trying to reduce the time it takes to unlock, gather and clean the one terabyte of data a FlexFactory can generate every day.

At the Process Solutions User Group (PSUG) meeting, Kevin Seaver, Cytiva executive general manager, Automation and Digital, discussed how – through automation and process innovation – the company is streamlining deployment of biopharmaceutical production capacity on behalf of its clients.

The Common Problem with Uncommon Solutions

More Flexible, Scalable Systems

It takes time and money to develop and produce life-saving biopharmaceutical medications, so anything that can make production systems more flexible, scalable and quicker to implement can save these valuable resources.

This is why Cytiva has been collaborating with Rockwell Automation to streamline the process controls and automation of its bioreactors, FlexFactory production lines, and KUBio modular biomanufacturing units it operates worldwide.

Reducing Biopharmaceutical Costs

Bioprocessing applications include large-molecule and small-molecule processes. So, while traditional medicines are compounded from molecules with less than 60 atoms, biopharmaceuticals like insulin have molecules with hundreds of atoms; flu vaccines have more than 100,000. This complexity makes development and upstream and downstream production of these newer biopharmaceuticals increasingly complex and costly.

Like most industries, biopharma is challenged by downward price and time-to-market pressures, and adapting quickly to changing market demands. It can take five to seven years to build a new facility and begin full-scale production. If a drug maker can implement a single-use bioprocess facility in 12-18 months, that can save money and time and ultimately get life-saving medicines to market faster.

Optimizing Bioreactors in FlexFactory Lines

Biopharmaceuticals can start small with one type of process control, but over time that may scale to much larger production runs requiring more extensive control. Cytiva needed a better, more consistent way to scale up.

Cytiva's work with Rockwell Automation has provided a flexible scalable platform that supports this growth. It offers many benefits, including a scalable line of Figurate bioreactors in its FlexFactory family, which can be deployed in its KUBio prefabricated modular clean rooms.

Automation Benefits Bioprocesses

Cytiva's strategy for addressing these multiple challenges in its biopharmaceutical application includes taking advantage of automation, flexibility and efficiency that will:

  • Optimize uptime due to system redundancy
  • Reduce maintenance and training by using a common framework
  • Optimize yield with centralized data trending and alarming
  • Reduce regulatory exposure with GAMP-proven and CFR-compliant designs

Cytiva adopted the PlantPAx® modern DCS to automate its bioprocess equipment; make their data available by integrating it with applicable manufacturing execution system (MES) applications and electronic batch records (EBR); and also provide it to cloud-computing services.

The benefits include 10-20% increases in production throughput, availability and production employee efficiency, as well as 5-30% decreases in energy use, scrap material, batch release time, maintenance, and downtime investigations.

Cytiva is also working with Rockwell Automation and PTC to create augmented reality (AR) operator support tools. For example, its operators can use AR image capture to display and manipulate images that show pH, dissolved oxygen, carbon dioxide, control cabinet performance and other crucial parameters more quickly. PTC Vuforia® Chalk™ software even allows operators and supervisor to mark up images to point out details that need to be addressed.

Learn more about our automation, process control, and information solutions in biotech industry.

Jim Montague
Jim Montague
Executive Editor, Control

Subscribe to Rockwell Automation and receive the latest news, thought leadership and information directly to your inbox.

Recommended For You